Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Aug 5, 2020
Date Accepted: Feb 22, 2021
Date Submitted to PubMed: May 25, 2021

The final, peer-reviewed published version of this preprint can be found here:

State of the Art in Adoption of Contact Tracing Apps and Recommendations Regarding Privacy Protection and Public Health: Systematic Review

Kolasa K, Mazzi F, Leszczuk-Czubkowska E, Zrubka Z, Péntek M

State of the Art in Adoption of Contact Tracing Apps and Recommendations Regarding Privacy Protection and Public Health: Systematic Review

JMIR Mhealth Uhealth 2021;9(6):e23250

DOI: 10.2196/23250

PMID: 34033581

PMCID: 8195202

An Overview of Contact Tracing Applications Between Privacy Protection and Public Health: State-of-the-Art and Recommendations

  • Katarzyna Kolasa; 
  • Francesca Mazzi; 
  • Ewa Leszczuk-Czubkowska; 
  • Zsombor Zrubka; 
  • Márta Péntek

ABSTRACT

Background:

The ongoing COVID-19 pandemic has resulted in the rapid implementation of data-driven innovation, as part of the efforts to curtail the spread of the virus. However, not all digital solutions have been launched expeditiously. A case in point is the adoption of contact tracing mobile applications, although they triggered a debate regarding the issue of data privacy. The objective of our study is to discuss the effective use of digital solutions that are in compliance with data privacy regulations.

Objective:

To address the question how to strike the balance between the data accessibility and data confidentiality to ensure the greatest benefit of contact tracing mobile applications.

Methods:

A systematic review of Pubmed, Medbase, and grey literature was performed. To ensure a standardised approach for reviewing contact tracing applications, two checklists assessing both effectiveness and compliance with data privacy were developed. Based on a scorecard comprising 16 criteria, the ranking of digital solutions was also conducted.

Results:

Overall, 18 applications were reviewed. While seven provided a definition of contact tracing, eight allowed for COVID-19 test result verification and only one defined the efficiency threshold. Explicit consent was requested in 15, and anonymisation techniques and data retention were provided in 14 and 13, respectively. Compliance with data minimisation in terms of Bluetooth was reported in seven cases. Principally, 10 applications collected additional information, of which six adopted anonymisation and/or aggregation for data sharing with a third party. The decentralised approach was identified in eight of 18 cases. With regard to ranking, COVIDSafe received the maximum score (15 of 16 points), while Alipay Health Code ranked last (-3 of 16 points).

Conclusions:

The compliance with data privacy was the highest with respect to explicit consent and data retention while the lowest with respect to data minimization and sharing in anonymised and aggregated manner. There is still a room for improvement in terms of the usefulness of digital contact tracing in the compliance with data privacy regulations.


 Citation

Please cite as:

Kolasa K, Mazzi F, Leszczuk-Czubkowska E, Zrubka Z, Péntek M

State of the Art in Adoption of Contact Tracing Apps and Recommendations Regarding Privacy Protection and Public Health: Systematic Review

JMIR Mhealth Uhealth 2021;9(6):e23250

DOI: 10.2196/23250

PMID: 34033581

PMCID: 8195202

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.